List of works - Eleonora Cimini

Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course

scientific article

Bone Marrow CD34+ Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory Cytokines.

scientific article published on 26 January 2017

CD3zeta down-modulation may explain Vgamma9Vdelta2 T lymphocyte anergy in HIV-infected patients

scientific article

Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.

scientific article

Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients

scientific article

Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients.

scientific article

Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections

scientific article

Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells: a case report.

scientific article published on 20 January 2015

Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level

scientific article published on 2 January 2017

HCV-DAA therapy impacts on extracellular vesicles miRNAs content and on their immunomodulating properties

scientific article published on 22 January 2018

HIV infection of monocytes-derived dendritic cells inhibits Vγ9Vδ2 T cells functions

scientific article

HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection

scientific article published on 7 April 2017

Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells

scientific article published on 24 July 2017

IL-18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV-infected patients treated during primary HIV infection

scientific article published on 8 January 2018

In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition.

scientific article published on 9 September 2015

In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals.

scientific article

In vivo interferon-alpha/ribavirin treatment modulates Vγ9Vδ2 T-cell function during chronic HCV infection

scientific article published on 11 January 2013

Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection

scientific article (publication date: 2012)

Interferon‐γ–Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells

scientific article published in 2006

Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication.

scientific article

Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.

scientific article published on 31 March 2016

Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein

scientific article published on 19 March 2014

Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery

article published in 2011

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions.

scientific article published on 18 June 2015

Short Communication: The 2005 Italian Quality Control Study for the Evaluation of CD4 Cells in Centers Involved in the Treatment of HIV Type 1 Patients

article

Unique human immune signature of Ebola virus disease in Guinea

scientific article

Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count

scientific article published on 10 July 2015

List of works by Eleonora Cimini

Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course

Bone Marrow CD34+ Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory Cytokines.

CD3zeta down-modulation may explain Vgamma9Vdelta2 T lymphocyte anergy in HIV-infected patients

Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.

Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients

Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients.

Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections

Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells: a case report.

Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level

HCV-DAA therapy impacts on extracellular vesicles miRNAs content and on their immunomodulating properties

HIV infection of monocytes-derived dendritic cells inhibits Vγ9Vδ2 T cells functions

HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection

Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells

IL-18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV-infected patients treated during primary HIV infection

In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition.

In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals.

In vivo interferon-alpha/ribavirin treatment modulates Vγ9Vδ2 T-cell function during chronic HCV infection

Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection

Interferon‐γ–Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells

Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication.

Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.

Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein

Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions.

Short Communication: The 2005 Italian Quality Control Study for the Evaluation of CD4 Cells in Centers Involved in the Treatment of HIV Type 1 Patients

Unique human immune signature of Ebola virus disease in Guinea

Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count